Company or ticker...

Madrigal Pharmaceuticals

Madrigal Pharmaceuticals is a clinical-stage biopharmaceutical company dedicated to developing novel therapeutics for non-alcoholic steatohepatitis (NASH) and other liver diseases.

Ticker

M. Cap

PS

PE

YTD

10MA

20MA

50MA

200MA

MDGL

12.6B

11.2

n/a

-6.04%

Key Facts

M. Cap

PS

PE

YTD

12.6B

11.2

n/a

-6.04%

10MA

20MA

50MA

200MA

$MDGL